» Articles » PMID: 26086446

The Potential Role of an Expert Computer System to Augment the Opportunistic Detection of Individuals with Familial Hypercholesterolaemia from a Community Laboratory

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 2015 Jun 19
PMID 26086446
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial hypercholesterolaemia (FH) is the most common monogenic cause of premature atherosclerotic cardiovascular disease (CVD). However, most individuals with FH remain undiagnosed. We sought to determine if an expert system (ES) at a community laboratory could identify information relevant for estimating an individual's likelihood of FH using the Dutch Lipid Clinic Network criteria (DLCNC).

Methods: An ES (RippleDown®) retrospectively analysed laboratory results and clinical details on the current and previous lipid requests from a community laboratory in Western Australia, over 12months.

Results: 84,823 individuals had ≥1 LDL-cholesterol request with data available on 84,083 (99.1%). Clinical details were provided on 71,282 (84.8%) individuals' current or previous requests. History relevant to the DLCNC was present in 883 (1.1%) individuals, with premature CVD and non-cardiac vascular disease present in 177 and 64 individuals, respectively. Statin therapy was reported in 5118 individuals; 112 individuals with a current LDL-cholesterol of <6.5mmol/L had a previous LDL-cholesterol of ≥6.5mmol/L.

Conclusions: The ES was able to identify information that increased the likelihood of FH in 5471 cases. The ability to detect individuals with premature CVD and to classify them based on their highest LDL-cholesterol may augment FH detection, although further investigation is required to confirm this.

Citing Articles

Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience.

Silva L, Condon L, Qureshi N, Dutton B, Weng S, Kai J Br J Gen Pract. 2022; 72(720):e519-e527.

PMID: 35697509 PMC: 9208733. DOI: 10.3399/BJGP.2021.0558.


Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.

Qureshi N, Da Silva M, Abdul-Hamid H, Weng S, Kai J, Leonardi-Bee J Cochrane Database Syst Rev. 2021; 10:CD012985.

PMID: 34617591 PMC: 8495769. DOI: 10.1002/14651858.CD012985.pub2.


Systematic Identification of Familial Hypercholesterolaemia in Primary Care-A Systematic Review.

Silva L, Qureshi N, Abdul-Hamid H, Weng S, Kai J, Leonardi-Bee J J Pers Med. 2021; 11(4).

PMID: 33920869 PMC: 8071332. DOI: 10.3390/jpm11040302.


An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".

Pang J, Hu M, Lin J, Miida T, Nawawi H, Park J BMJ Open. 2017; 7(10):e017817.

PMID: 29074516 PMC: 5665281. DOI: 10.1136/bmjopen-2017-017817.


Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study.

Qureshi N, Weng S, Tranter J, El-Kadiki A, Kai J BMJ Open. 2016; 6(5):e011734.

PMID: 27231005 PMC: 4885432. DOI: 10.1136/bmjopen-2016-011734.